The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of metastasectomy in patients with early onset metastatic colorectal cancer.
 
Andrea Pretta
No Relationships to Disclose
 
Pina Ziranu
No Relationships to Disclose
 
Eleonora Perissinotto
No Relationships to Disclose
 
Raimondo Scalia
No Relationships to Disclose
 
Federica Marmorino
No Relationships to Disclose
 
Maria Caterina De Grandis
No Relationships to Disclose
 
Paolo Ciracì
No Relationships to Disclose
 
Alessandra Russo
No Relationships to Disclose
 
Krisida Cerma
No Relationships to Disclose
 
Chiara Cavalli
No Relationships to Disclose
 
Anna Chiaramonte
No Relationships to Disclose
 
Ada Taravella
No Relationships to Disclose
 
Riccardo Giampieri
No Relationships to Disclose
 
Rossana Berardi
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Otsuka; Roche
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Pierre Fabre; SERVIER
Speakers' Bureau - Bayer; BMS; Eisai; Lilly; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Janssen; Merck Serono; MSD Oncology; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Nordic Bioscience; Pierre Fabre; Roche
Speakers' Bureau - Merck; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER
 
Mario Scartozzi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Sanofi; GlaxoSmithKline; Merck; MSD; Rottapharm Biotech; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Sanofi; GlaxoSmithKline; Merck; MSD; SERVIER
Research Funding - Sanofi
Travel, Accommodations, Expenses - Merck; MSD; SERVIER